Sarepta Therapeutics, Inc. (SRPT)
17.73
-0.45
(-2.48%)
USD |
NASDAQ |
Oct 23, 16:00
17.70
-0.02
(-0.14%)
After-Hours: 20:00
Sarepta Therapeutics Price to Book Value : 1.226 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.226 |
| October 22, 2026 | 1.257 |
| October 21, 2026 | 1.283 |
| October 20, 2026 | 1.325 |
| October 19, 2026 | 1.226 |
| October 16, 2026 | 1.182 |
| October 15, 2026 | 1.230 |
| October 14, 2026 | 1.164 |
| October 13, 2026 | 1.141 |
| October 12, 2026 | 1.206 |
| October 09, 2026 | 1.234 |
| October 08, 2026 | 1.259 |
| October 07, 2026 | 1.210 |
| October 06, 2026 | 1.197 |
| October 05, 2026 | 1.209 |
| October 02, 2026 | 1.210 |
| October 01, 2026 | 1.215 |
| September 30, 2026 | 1.260 |
| September 29, 2026 | 1.289 |
| September 28, 2026 | 1.300 |
| September 25, 2026 | 1.291 |
| September 24, 2026 | 1.271 |
| September 23, 2026 | 1.310 |
| September 22, 2026 | 1.439 |
| September 21, 2026 | 1.392 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.390 |
| September 17, 2026 | 1.429 |
| September 16, 2026 | 1.366 |
| September 15, 2026 | 1.432 |
| September 14, 2026 | 1.446 |
| September 11, 2026 | 1.414 |
| September 10, 2026 | 1.419 |
| September 09, 2026 | 1.522 |
| September 08, 2026 | 1.448 |
| September 04, 2026 | 1.556 |
| September 03, 2026 | 1.589 |
| September 02, 2026 | 1.605 |
| September 01, 2026 | 1.475 |
| August 31, 2026 | 1.454 |
| August 28, 2026 | 1.442 |
| August 27, 2026 | 1.493 |
| August 26, 2026 | 1.345 |
| August 25, 2026 | 1.308 |
| August 24, 2026 | 1.253 |
| August 21, 2026 | 1.299 |
| August 20, 2026 | 1.329 |
| August 19, 2026 | 1.364 |
| August 18, 2026 | 1.246 |
| August 17, 2026 | 1.257 |
| August 14, 2026 | 1.251 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.327 |
| Moderna, Inc. | 11.81 |
| Arrowhead Pharmaceuticals, Inc. | 17.59 |
| Rocket Pharmaceuticals, Inc. | 0.6801 |
| Intellia Therapeutics, Inc. | 2.157 |
Price to Book Value Related Metrics
| PS Ratio | 0.9707 |
| PEG Ratio | -0.0217 |
| Price to Free Cash Flow | 32.85 |
| Price | 17.73 |
| Earnings Yield | -16.34% |
| Market Cap | 1.873B |
| PEGY Ratio | -0.0217 |